PRELUDE CAPITAL MANAGEMENT, LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 55 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$11,000
+22.2%
2,700
-3.6%
0.00%
Q2 2020$9,000
-57.1%
2,800
-58.2%
0.00%
-100.0%
Q4 2019$21,000
-64.4%
6,699
-49.1%
0.00%
-66.7%
Q3 2019$59,000
+1.7%
13,154
+37.0%
0.00%0.0%
Q2 2019$58,000
+65.7%
9,600
+92.0%
0.00%
+50.0%
Q1 2019$35,000
-5.4%
5,000
+8.7%
0.00%
-33.3%
Q1 2018$37,0004,6000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Western Standard LLC 869,354$2,895,0003.47%
22NW, LP 1,241,896$4,136,0002.24%
Newtyn Management, LLC 1,199,606$3,995,0001.46%
WITTENBERG INVESTMENT MANAGEMENT, INC. 186,198$620,0000.35%
Yakira Capital Management, Inc. 66,934$223,0000.10%
Sepio Capital, LP 210,534$701,0000.08%
Nantahala Capital Management 747,635$2,490,0000.08%
Watson Rebecca 3,068$10,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 61,700$205,0000.00%
WEBSTER BANK, N. A. 3,055$10,0000.00%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders